Loading...
Loading...
NewGenIvf Group Ltd
NewGenIvf Group Ltd. Spoken Alpha tracks NIVF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks NIVF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NIVF.
curl https://api.spokenalpha.com/v1/companies/NIVF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.37 | $0.44 | -16.7% | +8.7% | +9.6% |
| Q4 FY2026 | $0.38 | $0.48 | -20.7% | +4.2% | +6.3% |
| Q3 FY2026 | $0.53 | $0.56 | -5.9% | +7.2% | +6.5% |
| Q2 FY2026 | $0.55 | $0.64 | -13.9% | -1.7% | -2.1% |
| Q1 FY2025 | $0.46 | $0.50 | -7.8% | +0.6% | +2.8% |
| Q4 FY2025 | $0.40 | $0.43 | -6.4% | -1.3% | +0.5% |
| Q3 FY2025 | $0.35 | $0.44 | -20.4% | -0.7% | -3.3% |
| Q2 FY2025 | $0.51 | $0.55 | -7.6% | -2.3% | -3.5% |
| Q1 FY2024 | $0.48 | $0.55 | -12.8% | -0.6% | -2.1% |
| Q4 FY2024 | $0.53 | $0.59 | -10.4% | +9.1% | +12.0% |